Immunovant stockIMVT
Immunovant trades at $28.39, 37.5% below its 52-week high (Aug 19, 2026). The price is below its 50- and 200-day averages, a downtrend. +11.7% year to date, +20.3% over 12 months (S&P 500 over the same period: +8.8%). Next earnings report: Nov 9, 2026.
Ratings, candles, signals and the screener for IMVT — after you log in
Open the terminalFrequently asked questions about Immunovant
What is the Immunovant stock price?
At the close on Nov 5, 2026: $28.39 (−5.05% on the day). 52-week high: $45.42 on Aug 19, 2026. During the session the price is updated with a 15-minute delay, after the close with the day's final figures.
When does Immunovant report earnings?
The next quarterly report is on Nov 9, 2026. Last quarter, earnings per share changed −6% year over year, revenue 0%.
Does Immunovant pay dividends?
No, Immunovant does not pay dividends.
Where does Immunovant trade and how to buy it?
Ticker IMVT, exchange Nasdaq. You can buy it through a broker with access to US exchanges.
Should I buy Immunovant now?
We do not give buy or sell advice. Ratings, the detailed chart and signals for IMVT are in the terminal after you log in.